Comparing different adjuvants to improve vaccine effectiveness
ADJUVANT COMPARISON AND CHARACTERIZATION
This study is looking at different ingredients that help vaccines work better, so we can find out which ones are most effective for specific diseases, ultimately helping to create better vaccines for everyone.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Stanford University NIH-funded |
| Lab location | 1 site (Stanford, United States) |
| Project ID | NIH-11159358 on NIH RePORTER |
What this research studies
This research focuses on comparing various adjuvants used in vaccines to understand how they enhance immune responses. By analyzing both systemic and tissue-specific immune profiles, the study aims to identify which adjuvants work best with specific vaccines or disease targets. Collaborations among researchers will ensure standardized methods and the sharing of results, which will contribute to the development of more effective vaccines for infectious, allergic, and autoimmune diseases. The findings will be made publicly available to benefit the broader scientific community and improve vaccine strategies.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals with allergies, autoimmune diseases, or those seeking vaccination against infectious diseases.
Not a fit: Patients who do not have allergies, autoimmune diseases, or are not seeking vaccination may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of more effective vaccines that provide better protection against infectious diseases and improved treatments for allergic and autoimmune conditions.
How similar studies have performed: Previous research has shown promise in enhancing vaccine efficacy through the use of different adjuvants, indicating that this approach has potential for success.
Where this research is happening
Stanford, United States
- Stanford University — Stanford, United States (Active)
Researchers
- Principal investigator: Pulendran, Bali — Stanford University
- Study coordinator: Pulendran, Bali
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.